Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaarina Kowalec

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Multiple Sclerosis and Related Disorders|April 17, 2015
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosisKaarina Kowalec, Bruce Carleton, Helen Tremlett
Diagnostic Microbiology and Infectious Disease|May 3, 2016
Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutantCarla Osiowy, Kaarina Kowalec, Elizabeth Giles
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2025
Comorbidities, safety and persistence in phase III clinical trials in multiple sclerosisAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patientKaarina Kowalec, Eric M Yoshida, Anthony Traboulsee, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Neurology|February 13, 2024
Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial PopulationsAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
Neurology|September 13, 2024
Author Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial PopulationsAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
JAMA Neurology|September 18, 2024
Comorbidity and Disease Activity in Multiple SclerosisAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
Psychological Medicine|February 8, 2021
Genetic architecture of schizophrenia: a review of major advancementsSophie E Legge, Marcos L Santoro, Sathish Periyasamy, et al.
Health Science Reports|January 26, 2024
Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic reviewAmanda Wondrasek, Amber Fryza, Md Abdul Aziz, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis and Related Disorders|April 17, 2015
The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosisKaarina Kowalec, Bruce Carleton, Helen Tremlett
Diagnostic Microbiology and Infectious Disease|May 3, 2016
Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutantCarla Osiowy, Kaarina Kowalec, Elizabeth Giles
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2025
Comorbidities, safety and persistence in phase III clinical trials in multiple sclerosisAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patientKaarina Kowalec, Eric M Yoshida, Anthony Traboulsee, et al.
Neurology|June 20, 2020
Comorbidity is associated with disease activity in MS: Findings from the CombiRx trialAmber Salter, Kaarina Kowalec, Kathryn C Fitzgerald, et al.
Neurology|February 13, 2024
Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial PopulationsAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
Neurology|September 13, 2024
Author Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial PopulationsAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
JAMA Neurology|September 18, 2024
Comorbidity and Disease Activity in Multiple SclerosisAmber Salter, Samantha Lancia, Kaarina Kowalec, et al.
Psychological Medicine|February 8, 2021
Genetic architecture of schizophrenia: a review of major advancementsSophie E Legge, Marcos L Santoro, Sathish Periyasamy, et al.
Health Science Reports|January 26, 2024
Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic reviewAmanda Wondrasek, Amber Fryza, Md Abdul Aziz, et al.
Pageof 7